Home / Market News / $STLN

$STLN news and market catalysts

The 1 most recent market catalysts affecting $STLN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

1 catalysts 1 high impact 1 bullish 0 bearish Biotechnology/Pharmaceuticals

Aug 7, 2026 Corporate Catalyst Bullish Impact 92

Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY

Starling Oncology (STLN) announced its Q2 financial results, reporting a narrower loss per share of $(0.08) compared to $(0.15) in the prior year, representing a 46.67% improvement…

Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.